Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.

By G. Wollensak, E. Spoerl, T. Seiler. American journal of ophthalmology-glaucoma, 2003

2,848 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/23048d5189223878d57ea136854f15c2dfa22b57

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. E. Spoerl
2. T. Seiler

In Radiology, Nuclear Medicine and Imaging

1. G. Wollensak
2. E. Spoerl
3. T. Seiler

Citations in the corpus

• Complication and failure rates after corneal crosslinking (2009, background): “1358 In 2003, a halt in the progression of keratectasia after CXL was shown in eyes with documented progression before the treatment.(3) The authors found a decrease in maximum keratometry (K) readings and an improvement in visual acuity during the first postoperative years.”
• Increased resistance of crosslinked cornea against enzymatic digestion (2004, background): “In a clinical pilot study including eyes with progressive keratoconus and with a follow-up time of up to 4 years the progression of keratoconus could be stopped in all patients treated with riboflavin/UVA and regression with a reduction of the maximal keratometry readings by 2 diopters was achieved ”